Human trials of anti-viral drug to treat dengue at Belagavi as well

Photo of author

Scientists at Lucknow-based Central Drug Research Institute (CSIR-CDRI) claim to have developed medicine to treat dengue, Hindustan Times has reported. According to the report, a Mumbai-based pharmaceutical major has received permission from the Drug Controller General of India (DCGI) to conduct human testing of the drug.

Trials will be conducted at one medical college in each of the following cities: Kanpur, Lucknow, Agra, Mumbai, Thane, Pune, Aurangabad, Ahmedabad, Kolkata, Bengaluru, Mangalore, Belagavi, Chennai, Jaipur, Chandigarh, Visakhapatnam, Cuttack, Khurda and Nathdwara.

A dengue patient should be at least 18 years of age to be eligible for trials. Additionally, infection in the patient should have been confirmed 48 hours before the testing.


The patient will be kept in hospital for eight days, during which he will be administered the drug for seven days. He will be kept under observation for 17 days after being given the medicine.

It is pertinent to note that there is no specific medicine for the treatment of dengue. Patients are treated on the basis of symptoms.

Leave a Comment